Cargando…
Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making
AIMS: The validated HCM Risk-Kids model provides accurate individualized estimates of sudden cardiac death risk in children with hypertrophic cardiomyopathy (HCM). A second validated model, PRIMaCY, also provides individualized estimates of risk, but its performance and clinical impact has not been...
Autores principales: | Norrish, Gabrielle, Protonotarios, Alexandros, Stec, Maria, Boleti, Olga, Field, Ella, Cervi, Elena, Elliott, Perry M, Kaski, Juan P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666656/ https://www.ncbi.nlm.nih.gov/pubmed/37995093 http://dx.doi.org/10.1093/europace/euad330 |
Ejemplares similares
-
Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021) -
Outcomes following general anaesthesia in children with hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2019) -
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018) -
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives: Evidence for a Change in Paradigm
por: Norrish, Gabrielle, et al.
Publicado: (2019) -
Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)